文献速递乳腺外科

超顺磁性氧化铁纳米颗粒作为乳腺癌前哨淋巴结活检唯一示踪方法

Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer.
PubMed 文献 · Br J Surg · 2017-09-06

MONOS 前瞻性队列研究在两家医院比较 SPIO 与 99mTc 作为前哨淋巴结活检示踪剂的效果,共纳入 338 例乳腺癌患者 343 次操作。SPIO 单独使用是安全替代方案。

要点

  • SPIO 单独用于乳腺癌前哨淋巴结活检检出率与 99mTc 相当。
  • 术前注射 SPIO 较围术期注射检出率更高且检出淋巴结更多。
  • SPIO 注射后皮肤染色与保乳手术及乳晕周围注射相关。

核心结论

  • SPIO 单独作为示踪剂是安全的替代方案,结果与 99mTc 联合蓝染料的标准双示踪技术相当。
  • 术前注射 SPIO 可简化流程并提高示踪性能,皮肤染色可通过更深部的瘤周注射预防。

研究设计与样本

  • 前瞻性队列研究,在两家医院开展,一家使用 99mTc,另一家使用 SPIO。
  • 共纳入 338 例连续乳腺癌患者,实施 343 次操作;SPIO 用于 184 次操作,99mTc 标记示踪剂用于 159 次操作。

主要发现

  • 所有 SPIO 摄取的淋巴结均呈棕色。

临床怎么用

  • SPIO 可单独用于乳腺癌前哨淋巴结活检,无需常规联合 99mTc 或蓝染料。
  • 优先选择术前门诊注射 SPIO,以简化流程并提高检出效果。
  • 采用更深部的瘤周注射以减少皮肤染色风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sentinel node biopsy (SNB) using superparamagnetic iron oxide (SPIO) nanoparticles is a novel method in breast cancer. Several studies have verified the non-inferiority of SPIO compared with the standard use of radioisotope 99m Tc with or without blue dye. The aim of the MONOS study presented here was to evaluate the use of SPIO as a sole tracer and the efficacy of tracer injection in the preoperative setting. METHODS: This prospective cohort study was carried out in two hospitals, one using 99m Tc and the other SPIO. 99m Tc was injected in the morning of the day of surgery or the day before. SPIO was either injected before surgery in the outpatient clinic or 1 h before the operation. RESULTS: A total of 338 consecutive patients with breast cancer underwent 343 procedures; SPIO nanoparticles were used in 184 procedures and 99m Tc-labelled tracer in 159. Detection rates for SPIO and 99m Tc were 95·6 and 96·9 per cent respectively (P = 0·537). All nodes with SPIO uptake were coloured brown. Fewer nodes were retrieved with SPIO (mean 1·35 versus 1·89), regardless of whether blue dye was used (P < 0·001). Preoperative SPIO injection (58·7 per cent of procedures), a median of 16 (range 2-27) days before the procedure, was associated with a better tracer-specific detection rate (95·3 versus 86 per cent; P = 0·031) and retrieval of more nodes (mean 1·43 versus 1·03; P < 0·001) than perioperative administration. Skin staining was present in 39·9 per cent of patients, and was related to breast-conserving surgery and periareolar injection. CONCLUSION: The use of SPIO alone is a safe alternative, with results comparable to those of the standard dual technique using 99m Tc and blue dye. The efficacy of injection in the preoperative setting simplifies logistics and improves performance. Skin staining can be prevented by a deeper peritumoral injection.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Karakatsanis A, Daskalakis K, Stålberg P, et al. Superparamagnetic iron oxide nanoparticles as the sole method for sentinel node biopsy detection in patients with breast cancer. Br J Surg. 2017. PMID: 28877348. doi:10.1002/bjs.10606

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。